Imugene Ltd - BTKi cohort builds with 71% overall response rate
Imugene Ltd (ASX:IMU) is a clinical-stage immuno-oncology company that has transitioned from a wide-ranging pipeline into a highly-focused vehicle...
81 Views
Imugene Ltd - Two for two in BTKi azer-cel cohort
Imugene Ltd (ASX:IMU) is a clinical-stage immuno-oncology company that has transitioned from a wide-ranging pipeline into a highly-focused vehicle...
118 Views
Imugene Ltd - First complete response in BTKi azer-cel cohort
Imugene Ltd (ASX:IMU) is a clinical-stage immuno-oncology company that has transitioned from a wide-ranging pipeline into a highly-focused vehicle...
108 Views
Imugene Ltd - Several incremental positives in the past month
Imugene Ltd (ASX:IMU) is a clinical-stage immuno-oncology company that has transitioned from a wide-ranging pipeline into a highly-focused vehicle...
128 Views
Imugene Ltd - Off-the-shelf CAR-T
Imugene Ltd (ASX:IMU) is a clinical-stage immuno-oncology company that has transitioned from a wide-ranging (expensive) pipeline into a...
125 Views